Titan Biotech Limited (BOM:524717)

Titan Biotech Statistics

Total Valuation

Titan Biotech has a market cap or net worth of INR 8.17 billion. The enterprise value is 8.22 billion.

Market Cap	8.17B
Enterprise Value	8.22B

Important Dates

The next estimated earnings date is Tuesday, February 10, 2026.

Earnings Date	Feb 10, 2026
Ex-Dividend Date	Sep 19, 2025

Share Statistics

Titan Biotech has 8.26 million shares outstanding. The number of shares has increased by 0.02% in one year.

Current Share Class	8.26M
Shares Outstanding	8.26M
Shares Change (YoY)	+0.02%
Shares Change (QoQ)	-0.10%
Owned by Insiders (%)	8.81%
Owned by Institutions (%)	n/a
Float	2.65M

Valuation Ratios

The trailing PE ratio is 35.41.

PE Ratio	35.41
Forward PE	n/a
PS Ratio	4.69
PB Ratio	4.91
P/TBV Ratio	4.91
P/FCF Ratio	56.94
P/OCF Ratio	39.26
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 27.59, with an EV/FCF ratio of 57.30.

EV / Earnings	35.63
EV / Sales	4.72
EV / EBITDA	27.59
EV / EBIT	32.33
EV / FCF	57.30

Financial Position

The company has a current ratio of 2.78, with a Debt / Equity ratio of 0.05.

Current Ratio	2.78
Quick Ratio	1.03
Debt / Equity	0.05
Debt / EBITDA	0.32
Debt / FCF	0.62
Interest Coverage	80.46

Financial Efficiency

Return on equity (ROE) is 14.81% and return on invested capital (ROIC) is 10.97%.

Return on Equity (ROE)	14.81%
Return on Assets (ROA)	7.64%
Return on Invested Capital (ROIC)	10.97%
Return on Capital Employed (ROCE)	13.48%
Weighted Average Cost of Capital (WACC)	6.52%
Revenue Per Employee	3.73M
Profits Per Employee	493,884
Employee Count	467
Asset Turnover	0.93
Inventory Turnover	1.79

Taxes

In the past 12 months, Titan Biotech has paid 68.73 million in taxes.

Income Tax	68.73M
Effective Tax Rate	22.96%

Stock Price Statistics

The stock price has increased by +23.26% in the last 52 weeks. The beta is 0.42, so Titan Biotech's price volatility has been lower than the market average.

Beta (5Y)	0.42
52-Week Price Change	+23.26%
50-Day Moving Average	1,025.56
200-Day Moving Average	727.53
Relative Strength Index (RSI)	40.84
Average Volume (20 Days)	6,770

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Titan Biotech had revenue of INR 1.74 billion and earned 230.64 million in profits. Earnings per share was 27.91.

Revenue	1.74B
Gross Profit	893.83M
Operating Income	229.47M
Pretax Income	299.37M
Net Income	230.64M
EBITDA	268.55M
EBIT	229.47M
Earnings Per Share (EPS)	27.91

Balance Sheet

The company has 35.99 million in cash and 88.50 million in debt, with a net cash position of -52.51 million or -6.35 per share.

Cash & Cash Equivalents	35.99M
Total Debt	88.50M
Net Cash	-52.51M
Net Cash Per Share	-6.35
Equity (Book Value)	1.66B
Book Value Per Share	201.46
Working Capital	575.48M

Cash Flow

In the last 12 months, operating cash flow was 208.01 million and capital expenditures -64.59 million, giving a free cash flow of 143.42 million.

Operating Cash Flow	208.01M
Capital Expenditures	-64.59M
Free Cash Flow	143.42M
FCF Per Share	17.36

Margins

Gross margin is 51.28%, with operating and profit margins of 13.17% and 13.23%.

Gross Margin	51.28%
Operating Margin	13.17%
Pretax Margin	17.18%
Profit Margin	13.23%
EBITDA Margin	15.41%
EBIT Margin	13.17%
FCF Margin	8.23%

Dividends & Yields

This stock pays an annual dividend of 2.00, which amounts to a dividend yield of 0.20%.

Dividend Per Share	2.00
Dividend Yield	0.20%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	7.17%
Buyback Yield	-0.02%
Shareholder Yield	0.19%
Earnings Yield	2.82%
FCF Yield	1.76%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	4